Literature DB >> 28007749

Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications.

Joachim Winter1, Markus Siekiera2, Dong-In Shin2, Christian Meyer2, Patric Kröpil3, Harald Clahsen4, Stephen O'Connor5.   

Abstract

AIMS: The subcutaneous cardioverter defibrillator was designed to overcome electrode complications of transvenous defibrillation systems. While largely achieved, pocket complications have increased. Subcutaneous implantation of the pulse generator leaves it prone to erosion, extrusion, discomfort, and poor cosmesis. METHODS AND
RESULTS: We use a demonstration electrode and pulse generator with fluoroscopy, prior to prepping and draping, to maximize the left ventricular mass between them. We adapted a submuscular abdominal ICD technique to implant the S-ICD intermuscularly between the anterior surface of serratus anterior and the posterior surface of latissimus dorsi. Surgery in our patients beyond the subcutaneous tissue was bloodless, as muscle layers were carefully separated but not incised, which also protected the long thoracic nerve. Two layers of muscle protect the pulse generator. We have implanted 82 consecutive patients with this technique, taking ∼65 min. All patients were converted with 65 J standard polarity shock during induced arrhythmia conversion testing, with six (7.3%) patients requiring a repositioning of the pulse generator prior to successful conversion. Seven spontaneous episodes of ventricular fibrillation were detected in three (3.6%) patients, all successfully converted back to sinus rhythm. Long-term patient outcomes have been good with low complication rates over the mean ± standard deviation 3.6 ± 1.2 years.
CONCLUSION: Our intermuscular technique and implant methodology is successful for placement of the subcutaneous defibrillator pulse generator. Our technique leads to an excellent cosmetic result and high levels of patient satisfaction. Rates of first shock conversion during defibrillation testing, inappropriate shocks, and complications during follow-up compare favourably with previous published case series. There were no left arm movement limitations post-operatively. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Complications; Human; Intermuscular pulse generator implant; Subcutaneous implantable cardioverter-defibrillator

Mesh:

Year:  2017        PMID: 28007749     DOI: 10.1093/europace/euw297

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  14 in total

1.  Conscious sedation during subcutaneous implantable cardioverter-defibrillator implantation using the intermuscular technique.

Authors:  Elif Kaya; Rolf Alexander Jánosi; Obayda Azizy; Reza Wakili; Tienush Rassaf
Journal:  J Interv Card Electrophysiol       Date:  2018-09-14       Impact factor: 1.900

Review 2.  Pregnancy in patients with implantable cardiac defibrillators.

Authors:  Geoffrey R Wong; Megan Ang; Jasveer Jayarajan; Fiona Walker; Pier D Lambiase
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-05-10

3.  Ultrasound-guided serratus anterior plane block for subcutaneous implantable cardioverter defibrillator implantation using the intermuscular two-incision technique.

Authors:  Federico Migliore; Pietro De Franceschi; Manuel De Lazzari; Carlotta Miceli; Claudia Cataldi; Cinzia Crescenzi; Mauro Migliore; Demetrio Pittarello; Sabino Iliceto; Emanuele Bertaglia
Journal:  J Interv Card Electrophysiol       Date:  2020-01-03       Impact factor: 1.900

4.  The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience.

Authors:  Cesar Khazen; Peter Magnusson; Johannes Flandorfer; Christoph Schukro
Journal:  Cardiol J       Date:  2018-05-02       Impact factor: 2.737

5.  Revision of subcutaneous implantable cardioverter defibrillator to intermuscular pocket to prevent inappropriate shocks.

Authors:  Jeko M Madjarov; Svetozar Madzharov; Filip Abedinov; Stefanie Chappuis; John M Fedor
Journal:  Clin Case Rep       Date:  2020-04-15

6.  Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique.

Authors:  Federico Migliore; Giulia Mattesi; Pietro De Franceschi; Giuseppe Allocca; Martino Crosato; Vittorio Calzolari; Mauro Fantinel; Benedetta Ortis; Domenico Facchin; Elisabetta Daleffe; Tommaso Fabris; Elena Marras; Manuel De Lazzari; Francesco Zanon; Lina Marcantoni; Mariachiara Siciliano; Domenico Corrado; Sabino Iliceto; Emanuele Bertaglia; Massimo Zecchin
Journal:  J Cardiovasc Electrophysiol       Date:  2019-03-13

7.  Pre-implant screening guided by cardiac silhouette fluoroscopy: a way to increase eligibility for the subcutaneous implantable cardioverter-defibrillator: a case report.

Authors:  Victoria Galizia Brito; Aina Bibiloni Cladera; Maria Del Carmen Exposito Pineda; Carlos Grande Morales
Journal:  Eur Heart J Case Rep       Date:  2020-12-29

8.  Subcutaneous ICD implantation under ultrasound-guided serratus anterior plane block: Single-center experience in the Netherlands.

Authors:  Jan Elders; Hisham AlHashimi; Marc Gomes; Ivo Panhuizen; Sander van Kuijk; Kevin Vernooy
Journal:  Int J Cardiol Heart Vasc       Date:  2022-01-05

9.  Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland.

Authors:  Krzysztof Kaczmarek; Maciej Kempa; Marcin Grabowski; Mateusz Tajstra; Adam Sokal; Iwona Cygankiewicz; Radosław Zwoliński; Marcin Michalak; Michal Kowara; Szymon Budrejko; Anna Kurek; Jerzy K Wranicz; Grzegorz Raczak; Grzegorz Opolski; Mariusz Gąsior; Oskar Kowalski; Paweł Ptaszyński
Journal:  Arch Med Sci       Date:  2019-05-21       Impact factor: 3.318

10.  To the Editor- Strategy for revision of subcutaneous implantable cardioverter-defibrillator following inappropriate shock.

Authors:  Joachim Winter; Stephen O'Connor
Journal:  HeartRhythm Case Rep       Date:  2019-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.